Proposed sale of 64,540 common shares under registered plan (RYTM)
Rhea-AI Filing Summary
RYTM filing reports a proposed sale of 64,540 common shares on 03/04/2026 described as an exercise of options under a registered plan. The filing also records a sale of 35,460 common shares by Camille L. Bedrosian on 03/03/2026 for $3,209,778.92.
Positive
- None.
Negative
- None.
Insights
Form 144 notes a brokered resale following option exercise and a recent insider sale.
The entry lists 64,540 common shares to be sold on 03/04/2026, described verbatim as an exercise of options under a registered plan. This indicates shares resulting from option exercise are being presented for resale.
Examples shown include a prior sale by Camille L. Bedrosian of 35,460 shares on 03/03/2026 for $3,209,778.92. Subsequent filings will disclose actual sale completion and methods.
The notice follows standard resale procedures for restricted or control securities.
The excerpt lists Morgan Stanley Smith Barney LLC and identifies the transaction as involving the issuer and an exercise under a registered plan, verbatim. The broker line and plan descriptor align with routine resale mechanics.
Regulatory outcome depends on timing and transaction reporting; this filing documents intent rather than confirmed settlement.